CONSENT OF RICHARD A. EISNER & CO. LLP
Published on August 24, 1999
EXHIBIT 23.2
CONSENT OF INDEPENDENT ACCOUNTANTS
We consent to inclusion in this Post-Effective Amendment No. 8 to the
Registration Statement on Form SB-2 (File No. 33-91802) of our report dated
February 6, 1999 on our audits of the financial statements of Cytoclonal
Pharmaceutics Inc. as of December 31, 1998 and 1997 and for each of the years in
the three-year period ended December 31, 1998. We also consent to the reference
of our firm under the captions "Experts" and "Selected Financial Data" in the
Prospectus.
/s/ Richard A. Eisner & Company, LLP
- ------------------------------------
Richard A. Eisner & Company, LLP
New York, New York
August 17, 1999